responsible for Risperdal diabetes?
antipsychotic drugs, such as Risperdal used to be considered “wonder drugs”. But
that was before life-compromising Risperdal side effects -- such as the diabetes
and hyperglycemia, heart attacks, strokes and comas, NMS, and death -- were
disclosed to the public.
Armies of pharmaceutical lobbyists put financial pressure on the government
hierarchy to release drugs like Risperdal into the pharmaceutical buying public
who are bombarded with a million dollar ad campaign with the goal to ask their
doctor about this pill and that pill. Clinical studies, paid for by the
pharmaceutical companies, may be incomplete or inconclusive while the drugs are
still released and marketed. Many countries ban the use of harmful prescription
drugs that the American public is urged to keep taking. Rather than disclose
this information, the pharmaceutical companies find more medical conditions and
recommend Risperdal for the treatment to American patients.
Is the FDA strangled by too much bureaucratic red tape to really take
Risperdal patient safety seriously?
The atypical drugs seemed to have few of the side effects commonly associated
with high doses of older medications for psychosis. For many years, stories of
remarkable recoveries seemed to confirm early excitement. But then doctors
started prescribing them for other conditions than schizophrenia such as bipolar
mania, Alzheimer’s disease, dementia, personality disorders, depression, and
severe behavioral problems in children.
Janssen Pharmaceutica, a division of Johnson & Johnson healthcare empire is
responsible for misleading physicians and the American public in the safety of
prescribing Risperdal and its diminished quality of life side effects.
Do you have a Risperdal lawsuit?
Have you or your child been prescribed Risperdal? Are you suffering from
debilitating Risperdal side effects? You may have a Risperdal lawsuit. Contact
an expert Risperdal lawyer familiar with prescription Risperdal side effects.
Use the form below for a FREE no-obligation consultation today.